Ann‐Britt Nygaard
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 2
- Oncology 4
- Cancer Cells and Metastasis 3
- Co-authors
- Sofie Sølvsten Sørensen (3 shared papers)Thomas Christensen (3 shared papers)Bertil Romner (1 shared paper)Bodil Langbakk (1 shared paper)Mads Bak (1 shared paper)Niels H. H. Heegaard (1 shared paper)Anting Liu Carlsen (1 shared paper)Thore Hillig (3 shared papers)
In The Last Decade
Ann‐Britt Nygaard
7 papers receiving 435 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 242
- Neurology 40
- Neurology 50
- Molecular Biology 244
- Oncology 41
Countries citing papers authored by Ann‐Britt Nygaard
This map shows the geographic impact of Ann‐Britt Nygaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Britt Nygaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Britt Nygaard more than expected).
Fields of papers citing papers by Ann‐Britt Nygaard
This network shows the impact of papers produced by Ann‐Britt Nygaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Britt Nygaard. The network helps show where Ann‐Britt Nygaard may publish in the future.
Co-authors
The 16 scholars most cited alongside Ann‐Britt Nygaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 137 | |
| 2 | 2014 | 128 | |
| 3 | 2017 | 68 | |
| 4 | 2015 | 46 | |
| 5 | 1998 | 44 | |
| 6 | 2013 | 16 | |
| 7 | 2014 | 1 | |
| 8 | Is metronomic chemotherapy less toxic than conventional chemotherapy in the randomized phase 2 XeNa trial combining navelbine oral and Xeloda for HER2 negative breast cancer patients | 2015 | 0 |
About Ann‐Britt Nygaard
Ann‐Britt Nygaard is a scholar working on Cancer Research, Oncology, Molecular Biology, Biomedical Engineering and Pathology and Forensic Medicine, having authored 8 papers that have together received 440 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cancer Cells and Metastasis (3 papers), Cancer Genomics and Diagnostics (2 papers), 3D Printing in Biomedical Research (2 papers), Cancer Research and Treatments (1 paper), Chemical Reactions and Isotopes (1 paper), Traumatic Brain Injury and Neurovascular Disturbances (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Cancer Research (242 citations), Neurology (40 citations), Neurology (50 citations), Molecular Biology (244 citations) and Oncology (41 citations). Ann‐Britt Nygaard has collaborated with scholars based in Denmark and Norway. Frequent co-authors include Sofie Sølvsten Sørensen, Thomas Christensen, Bertil Romner, Bodil Langbakk, Mads Bak, Niels H. H. Heegaard, Anting Liu Carlsen, Thore Hillig, György Sölétormos and Ivan Brandslund. Their work appears in journals such as Apmis, Tumor Biology, Biomarker Research, Annals of Oncology and Translational Stroke Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.